Canton Strategic Holdings (CNTN) Common Equity (2020 - 2026)
Canton Strategic Holdings posted quarterly Common Equity of $469.8 million for Q1 2026, up 57767.37% year-on-year from N/an in Q1 2025, and up 18.06% on a QoQ basis from $397.9 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 7 years of Common Equity data on file, last reported at $469.8 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 57767.37% year-over-year to $469.8 million; the trailing twelve-month figure through Mar 2026 stood at $469.8 million (up 57767.37% YoY), and the FY2025 full-year result was $397.9 million, up 30330.8% from the prior year.
- Common Equity for Q1 2026 stood at $469.8 million, up from $397.9 million in the prior quarter.
- Across five years, Common Equity topped out at $469.8 million in Q1 2026 and bottomed at -$814671.0 in Q1 2025.
- The 5-year median for Common Equity is $6.2 million (2025), against an average of $55.3 million.
- The widest annual swing landed in 2025, when Common Equity slumped 111.56%; it then jumped 57767.37% in 2026.
- A 5-year view of Common Equity shows it stood at $5.5 million in 2022, then jumped by 64.72% to $9.1 million in 2023, then sank by 85.68% to $1.3 million in 2024, then surged by 30330.8% to $397.9 million in 2025, then gained by 18.06% to $469.8 million in 2026.
- The last three Common Equity figures came in at $469.8 million (Q1 2026), $397.9 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | 469.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 469.80 Mn |
| Dec 31, 2025 | 397.93 Mn |
| Sep 30, 2025 | 6.15 Mn |
| Jun 30, 2025 | 367,359.00 |
| Mar 31, 2025 | -814,671.00 |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 6.69 Mn |
| Mar 31, 2024 | 7.05 Mn |
| Dec 31, 2023 | 9.13 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 3.07 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 5.54 Mn |
| Sep 30, 2022 | 7.12 Mn |
| Jun 30, 2022 | 9.04 Mn |
| Mar 31, 2022 | 10.34 Mn |
| Dec 31, 2021 | -4.68 Mn |
| Sep 30, 2021 | -7.14 Mn |
| Jun 30, 2021 | -6.30 Mn |
| Mar 31, 2021 | -5.29 Mn |
| Dec 31, 2020 | -3.72 Mn |